Quick Answer
Celularity Inc reported Stockholders Equity of $8.84 million for the year ending 2024.
- Celularity Inc showed a decrease of -78.4% in Stockholders Equity from 2023 to 2024.
- This data is from Celularity Inc's annual report (Form 10-K), filed with the SEC on May 8, 2025.
- XBRL data for this metric is available from 2018 to 2024 (7 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q3 2018: $24.5 thousand | Q1 2019: $23.8 thousand | Q2 2019: $5.00 million | Q3 2019: $5.00 million | Q1 2020: -$356.78 million | Q2 2020: -$490.95 million | Q3 2020: -$536.41 million | Q1 2021: -$611.93 million | Q2 2021: -$648.21 million | Q3 2021: $96.22 million | Q1 2022: $89.91 million | Q2 2022: $150.15 million | Q3 2022: $164.24 million | Q1 2023: $155.63 million | Q2 2023: $118.50 million | Q3 2023: $30.25 million | Q4 2023: $40.96 million | Q1 2024: $31.25 million | Q2 2024: $27.81 million | Q3 2024: $17.28 million | Q4 2024: $8.84 million | Q1 2025: -$5.51 million | Q2 2025: -$25.50 million | Q3 2025: -$20.09 million.
- Over the full 7 years of available data (2018 to 2024), Celularity Inc's Stockholders Equity has grown by 36,871.8%.
- Historical annual values: Fiscal year 2024: $8.84 million | Fiscal year 2023: $40.96 million | Fiscal year 2022: $198.90 million | Fiscal year 2021: $99.42 million | Fiscal year 2020: -$531.40 million | Fiscal year 2019: -$327.42 million | Fiscal year 2018: $23.9 thousand.
- Data sourced from SEC EDGAR public filings as of August 6, 2026.
Last verified: